SE369275
The physiologic availability of a muscle relaxant, 1-[5-(p-nitrophenyl)furfurylideneamino]hydantoin, in the form of its sodium salt when administered orally to man in capsule form containing a formulation comprising it, lactose, starch, talc and magnesium stearate is increased at least twofold.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The physiologic availability of a muscle relaxant, 1-[5-(p-nitrophenyl)furfurylideneamino]hydantoin, in the form of its sodium salt when administered orally to man in capsule form containing a formulation comprising it, lactose, starch, talc and magnesium stearate is increased at least twofold. |
|---|